Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins.
about
Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparinTargeted Inhibition of Snail Activity in Breast Cancer Cells by Using a Co(III) -Ebox Conjugate.Role of the blood-brain barrier in the formation of brain metastases.Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation.Structural characteristics and biological activity of Fucoidans from the brown algae Alaria sp. and Saccharina japonica of different reproductive status.Finding melanoma drugs through a probabilistic knowledge graph
P2860
Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malignant melanoma as a target ...... ic properties of the heparins.
@en
Malignant melanoma as a target ...... ic properties of the heparins.
@nl
type
label
Malignant melanoma as a target ...... ic properties of the heparins.
@en
Malignant melanoma as a target ...... ic properties of the heparins.
@nl
prefLabel
Malignant melanoma as a target ...... ic properties of the heparins.
@en
Malignant melanoma as a target ...... ic properties of the heparins.
@nl
P2093
P2860
P1476
Malignant melanoma as a target ...... ic properties of the heparins.
@en
P2093
Anthony Maraveyas
Miriam J Johnson
Yu Pei Xiao
P2860
P2888
P304
P356
10.1007/S10555-010-9263-Y
P50
P577
2010-12-01T00:00:00Z